Gelesis Closes $16M Series A to Fund its Obesity Program
With plans to target the ballooning obesity market, Gelesis Inc. raised $16 million in its Series A financing.
The Boston-based company has remained under the radar since its founding in 2006, and Eric Elenko, interim vice president of business development, declined to comment on its technology or pipeline.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST